Effect of Alcohol Intake on Inflammatory Status and Prognosis in Cancer Patients
Xiangliang Liu,Wenxin Zhang,Wei Ji,Kaiwen Zheng,Yixin Zhao,Yuwei He,Jiuwei Cui,Wei Li
DOI: https://doi.org/10.2147/jir.s376248
IF: 4.5
2022-10-11
Journal of Inflammation Research
Abstract:Xiangliang Liu, 1, &ast Wenxin Zhang, 2, &ast Wei Ji, 1, &ast Kaiwen Zheng, 1 Yixin Zhao, 1 Yuwei He, 1 Jiuwei Cui, 1 Wei Li 1 1 The First Hospital of Jilin University, Changchun, People's Republic of China; 2 Zhongnan Hospital, Wuhan University, Wuhan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jiuwei Cui; Wei Li, Jilin University, Xinmin St No. 126, Changchun, 130021, People's Republic of China, Tel +8613844095420 ; +8613206282295, Fax +86 431-85619254, Email ; Purpose: To explore the effect of alcohol on the inflammatory status and prognosis of patients with malignancy. Patients and Methods: The clinical data of patients with malignant tumor who were admitted to the First Hospital of Jilin University from November 2011 to December 2018 were collected including basic clinical information, anthropometric indicators, body composition analysis, and serological indicators. Univariate and multivariate Cox proportional hazards models were performed to find predictors of survival. A nomogram was generated to indicate the interrelationships between the variables in the prediction model and the extent to which alcohol consumption affects prognosis. The C-index and calibration curves were used to verify the predictive accuracy of the scoring system. Results: A total of 2929 cancer patients were included in this study, of which 552 (18.8%) patients had alcohol consumption habits and 2377 (81.2%) patients had no alcohol history. Patients in the Alcohol group had significantly shorter overall survival (OS) than the Non-Alcohol group, and further sub-analysis indicated alcohol consumption was significantly associated with prognosis of advanced breast cancer (HR = 4.617, 95% CI 1.361– 15.664, p=0.014), and early stage hepatocellular carcinoma (HCC) without viral hepatitis (HR = 8.933, 95% CI 1.444– 55.275, p = 0.019). Multivariate Cox regression models also demonstrated that daily alcohol intake was a risk factor of survival benefits (HR = 1.256, 95% CI 1.016– 1.554, p = 0.036). Finally, a nomogram was constructed and the c-index of this scoring system is 0.751. The 3- and 5-year calibration curves of the model show a high agreement between the predicted probability and the actual observed survival rate. Conclusion: Alcohol intake was demonstrated associates with patient outcomes. A human component-prognosis scoring system was established to predict the survival benefits of cancer patients. Keywords: alcohol, inflammation, cancer, prognosis In 2020, the International Agency for Research on Cancer (IARC) led several research institutions to publish a significant study on alcohol drinking and cancer. 1 The study results that alcohol consumption is one of the critical risk factors for the global disease burden causally associated with various injuries and diseases, including cancer, and no safe dose exists. 2 The 2018 white paper "Moderate Drinking Status of Chinese Drinking Population" shows that the Chinese drinking population is as high as 600 million. Moreover, for about 36% of the East Asian people, there is a common loss-of-function variant in the ALDH2 gene on chromosome 12 (rs671), which significantly reduces the rate of acetaldehyde decomposition and aggravates the damage of acetaldehyde to various tissues and organs. 3 At present, there is a lot of evidence indicating that alcohol consumption is strongly associated with the risk of the occurrence of multiple cancers, 4,5 but the extent of harm of alcohol consumption in patients with different cancers remains to be explored, and there are many missing data, especially in China. Therefore, the aim of this large retrospective cohort study was to deeply investigate the effect of alcohol consumption on the prognosis of cancer patients. We collected clinical data from November 2011 to December 2018 from the Department of Oncology, Cancer Center, First Hospital of Jilin University. Inclusion criteria: (1) Clear diagnosis of malignancy in pathological specimens. (2) Age ≥ 18 years. (3) No nutritional support treatment prior to nutritional assessment and laboratory testing. Exclusion criteria: (1) Death within 30 days of hospital admission. (2) Mixed types of tumor. (3) Patients who declined to participate. Finally, 2929 patients were involved. Patients with multiple hospitalizations were considered as one case, and data from the first investigation were analyzed. All patients were regularly followed up by telephone interviews or outpatient visits. All pathological staging was defined according to the 8th edition of the American Joint Committee -Abstract Truncated-
immunology